Immediate Impact
57 standout
Citing Papers
Guidelines of care for the management of acne vulgaris
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of A. Lévy being referenced
Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patients
2007
Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Lévy | 65 | 110 | 94 | 14 | 209 | |
| Rakesh Singh | 91 | 98 | 45 | 17 | 269 | |
| Therezia Bokor‐Billmann | 21 | 40 | 58 | 9 | 132 | |
| Martin Schlaeger | 27 | 143 | 23 | 18 | 255 | |
| Jacob Groenendyk | 37 | 40 | 38 | 13 | 277 | |
| Carolyn Staines | 100 | 88 | 17 | 14 | 267 | |
| David Casson | 150 | 27 | 98 | 9 | 276 | |
| Denise Casey | 36 | 25 | 13 | 15 | 227 | |
| Leif Strömberg | 33 | 89 | 60 | 18 | 275 | |
| Wajiha Shaikh | 13 | 44 | 28 | 16 | 240 | |
| Meredith A. Olson | 42 | 31 | 32 | 9 | 295 |
All Works
Login with ORCID to disown or claim papers
Loading papers...